Inhibition of PHPT1 by phenylarsonic acids

Area of Science:

• Biochemistry
• Chemical Biology
• Enzymology

Background:

• Human protein histidine phosphatase PHPT1 plays roles in cellular pathways and cancer.
• Understanding PHPT1's biological functions is limited by a lack of specific chemical tools.
• Developing selective inhibitors is key to studying PHPT1 activity.

Purpose of the Study:

• To identify novel chemical scaffolds that inhibit PHPT1 activity.
• To develop the first peptide-based inhibitors for PHPT1.
• To investigate the mechanism of inhibition and selectivity of these novel compounds.

Main Methods:

• Identification of phenylarsonic acids as PHPT1 inhibitors.
• Design and synthesis of peptide-based phenylarsonic acid inhibitors.
• Enzyme inhibition assays and counterscreens against other phosphatases.
• Mechanistic studies including reduction in situ and site-directed mutagenesis of cysteine residues.

Main Results:

• Phenylarsonic acids were identified as general scaffolds inhibiting PHPT1.
• The first peptide-based PHPT1 inhibitors were developed by embedding phenylarsonic acids into peptides.
• The compounds showed some selectivity for PHPT1 over other phosphatases.
• Inhibition was found to be mixed, dependent on the reduction of phenylarsonic acids to thiophilic As(III) species.
• Mutational analysis indicated that cysteine residues in PHPT1 are important for inhibition.

Conclusions:

• Phenylarsonic acids and their peptide conjugates are effective inhibitors of PHPT1.
• These inhibitors provide valuable chemical tools for studying PHPT1.
• The mechanism of inhibition involves the formation of As(III) species that interact with cysteine residues.
• Further research into these inhibitors could lead to therapeutic strategies for PHPT1-related diseases.